Odense University Hospital — Sponsor Intelligence | 51 EU Trials

Filter these 51 trials by condition, phase, country and more.

Open in Search →

51 Registered trials

30 Recruiting

11 Completed trials

12 Countries active

81 Unique IMPs

100% Results reported

Phase III

Phase II

Phase IV

Phase III: 12 Phase II/III: 2 Phase II: 20 Phase III/IV: 2 Phase IV: 13 Phase I (Other): 1 Phase I (FiH): 1

Oversight events:

1 temporary halt across 1 trial

View oversight register →

100%

11 of 11 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Cardiac arrest 2 Chronic kidney disease 2 Type 2 diabetes mellitus 1 Osteopenia 1 Proteinuria 1 Congenital nephrogenic diabetes insipidus 1 Colorectal cancer 1 Pancreatitis chronic 1 Osteoporosis 1

Top IMPs

DAPAGLIFLOZIN 3 HUMAN SERUM ALBUMIN 2 SODIUM CHLORIDE 2 ACETYLSALICYLIC ACID 1 ADRC 1 ADRC001 1 AMILORIDE HYDROCHLORIDE DIHYDRATE 1 ATENOLOL 1 CARVEDILOL 1 CEFUROXIME 1 ELRANATAMAB 1 EMPAGLIFLOZIN 1

All trials

51 total

Senolytics to Improve Osteoporosis therapy: A randomised controlled clinical trial The SENIOR Trial Not authorised

2022-500669-28-00 Phase II 1 country
An European multinational study of a personalized approach of human albumin administration in patients with cirrhosis of the liver and compl… Not authorised

2022-501006-34-00 Phase III 6 countries HUMAN SERUM ALBUMIN; SODIUM CHLORIDE
Effect of Allogenic Ex-vivo Expanded Bone Marrow Derived Mesenchymal Stem Cells on Knee Osteoarthritis – A Randomized Controlled Trial Not authorised

2023-503974-19-00 Phase II/III 1 country
Epinephrine versus Isoprenaline During Out-of-Hospital Cardiac Arrest with Non-Shockable Rhytm (EPISO) Not authorised

2024-516074-29-00 Phase III 1 country EPINEPHRINE; ISOPRENALINE HYDROCHLORIDE
Repurposing Everolimus to enhance musculoskeletal Vitality and Ageing in The Elderly (RENOVATE) Pending

2023-509838-19-00 Phase II 1 country EVEROLIMUS; TETRACYCLINE HYDROCHLORIDE BP
Use of Isoprenaline with Epinephrine During Out-of-Hospital Cardiac Arrest with Non-Shockable Rhytm (EPISO) Pending

2024-516074-29-01 Phase III 1 country
The SGL-TX-PTDM study Pending

2024-518774-14-00 Phase II 1 country DAPAGLIFLOZIN
The MAYA2 trial Pending

2025-521941-25-00 Phase II 1 country
COPE-CP: The effect of Celecoxib on pain, quality of life, use of opioids, and inflammation in patients suffering from chronic pancreatitis Pending

2025-522956-25-00 Phase III 1 country PANTOPRAZOLE SODIUM SESQUIHYDRATE
SCARFREE-001: Verteporfin for Scar Prevention Pending

2025-525083-14-00 Phase II 1 country
Short title: A novel concept for local treatment of the elderly and fragile women with advanced ovarian cancer. Recruiting

2025-522269-30-00 Phase II 1 country
The Efficacy of Pressurised Intraperitoneal aerosol chemotherapy (PIPAC) combined with CURativE intent minimally invasive radical resection … Recruiting

2024-516194-76-00 Phase II 3 countries
TRI-AB trial Recruiting

2024-520251-24-00 Phase IV 1 country
MOVE-IT Recruiting

2024-517123-39-00 Phase IV 1 country
Treatment of Gastroesophageal Reflux Disease in Infants- a Randomized Controlled Trial Recruiting

2022-502770-16-00 Phase III/IV 1 country
Resistance training and rapamycin to enhance bone formation in postmenopausal women (STRONGBONE) Recruiting

2024-520372-10-00 Phase II 1 country
Effect of methylphenidate on cancer-related fatigue in patients treated for a brain tumor during childhood or adolescence: Protocol for a ra… Recruiting

2023-507926-18-00 Phase III 1 country
SGL-TX-GFR SGLT2i safety and efficacy on kidney allograft function in non-diabetic kidney transplant recipients: A randomized, double-blind,… Recruiting

2024-518773-33-00 Phase IV 1 country DAPAGLIFLOZIN
FDG-PET/CT versus conventional CT for response monitoring in metastatic breast cancer: a multicenter randomized clinical trial (MONITOR-RCT) Recruiting

2023-508591-11-00 Phase III 3 countries
ALEXIS Recruiting

2023-510042-24-01 Phase IV 1 country
Impact of Angiotensin Receptor Blocker in aortic stenosis Recruiting

2024-518389-28-00 Phase IV 1 country
Targeting mTOR with everolimus and/or physical training for preventing postmenopausal bone loss and accelerated skeletal aging. The RapaLoad… Recruiting

2023-508093-28-00 Phase II 1 country
Beneficial effects of Amiloride on progression of Chronic Kidney Disease: A-CKA Recruiting

2022-500692-31-00 Phase II 1 country AMILORIDE HYDROCHLORIDE DIHYDRATE
Repairing Peri-Anal Fistulas with regenerative cell therapeutics (REP-PAF) Recruiting

2022-502659-73-01 Phase I (FiH) 1 country ADRC; ADRC001; CEFUROXIME; METRONIDAZOLE

Showing 1–24 of 51 trials

← All sponsors A–Z